Ophthalmology Times Europe E-News:
Having trouble viewing this e-mail? Click here. 		You are subscribed to Ophthalmology Times Europe.
Ophthalmology Times Europe E-News
Modern Medicine Network
 
 
 
 
In this issue
• Fenretinide for GA
• BTA injections for infantile esotropia
• Multicomponent IOL success
• Ocular prosthesis and MGD
 
 
Survey

Would you use fenretinide in patients with geographic atrophy?

Click here to vote

You can now follow us on Twitter:
www.twitter.com/oteurope

Contact Us
Click here to contact Felicity Thomas, editor.
April 4, 2013
Fenretinide has potential for GA
Oral drug fenretinide has potential for the treatment of geographic atrophy (GA), but further studies are required. More...
BTA injections can treat infantile esotropia
Botulinum toxin type A (BTA) injections, with or without sodium hyaluronate (SH), are effective and feasible for the treatment of infantile esotropia. More...
Event Profile
Congress of the French Society of Ophthalmology — SFO 2013
Dates: 11–14 May 2013
Venue: Palais des Congrès, Paris
The Congress of the French Society of Ophthalmology is in its 119th year. The issues tackled in the main lectures include: advances in gene therapy, macular pathologies, childhood glaucoma, corneal ulcerations and management of conjunctival melanoma. There will also be interactive surgical workshops and over 100 exhibition stands. Read More
Multicomponent IOL provides excellent vision
Multicomponent IOL implantation is safe, easy and provides excellent vision, according to a recent case series. More...
MGD management needed for ocular prosthesis wearers
Ocular prosthesis wearers may require clinical assessment and management for meibomian gland dysfunction (MGD). More...